Skip to main content

Advertisement

Log in

Fuchs’ heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

The purpose of this article is to report the development of Fuchs’ heterochromic cyclitis (FHC) secondary to toxoplasmosis chorioretinitis. The design is based on observational case series report. We report in this article six cases of typical FHC developing secondary to ocular toxoplasmosis. Intraocular immunoglobulin G production against Toxoplasma gondii was determined in the aqueous humor of five patients by calculation of the Goldmann–Witmer coefficient (GWC). The clinical examination revealed typical FHC with no active chorioretinal scar. We report on five women and one man (aged 33–64 years old; median 44.6 years) who developed FHC over a period of time ranging from 2–13 years. A positive GWC (>3) was found in four patients; of the two remaining patients one was negative and the other did not have anterior chamber paracentesis. Four patients were treated for an active ocular toxoplasmic lesion before the development of FHC with pyrimethamine, sulfadiazine and corticosteroids. Two patients had negative anti-toxoplasmic therapy for FHC (one with trimethoprim-sulfamethoxazole for 3 weeks and the other with pyrimethamine, sulfadiazine and corticosteroids for 8 weeks). One never had any treatment. All the patients had mild anterior chamber reaction with no synechia, diffuse and characteristic white stellate keratic precipitates and vitritis; five patients had posterior subcapsular cataract and heterochromia and three had elevated intraocular pressure. The findings help us to conclude that FHC can develop over a period of time after ocular toxoplasmosis. This could be a main association to search for when a Fuchs’ uveitis is found with a chorioretinal scar. Ocular inflammation does not mean reactivation of ocular toxoplasmosis. FHC could be a secondary immune reaction with a past antigenic stimulation to a previous infection, i.e., toxoplasmosis, etc.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Bonfioli AA, Curi AL, Orefice F (2005) Fuchs’ heterochromic cyclitis. Semin Ophthalmol 20(3):143–146

    Article  PubMed  Google Scholar 

  2. Jones NP (1991) Fuchs’ heterochromic uveitis: a reappraisal of the clinical spectrum. Eye 5(Pt 6):649–661

    Article  PubMed  Google Scholar 

  3. Jones NP (1991) Glaucoma in Fuchs’ heterochromic uveitis: aetiology, management and outcome. Eye 5(Pt 6):662–667

    Article  PubMed  Google Scholar 

  4. Van Gelder RN (2008) Idiopathic no more: clues to the pathogenesis of Fuchs heterochromic iridocyclitis and glaucomatocyclitic crisis. Am J Ophthalmol 145(5):769–771

    Article  PubMed  Google Scholar 

  5. Makley TA Jr (1956) Heterochromic cyclitis in identical twins. Am J Ophthalmol 41(5):768–772

    PubMed  Google Scholar 

  6. Spriewald BM, Lefter C, Huber I et al (2007) A suggestive association of Fuch’s heterochromic cyclitis with cytotoxic T cell antigen 4 gene polymorphism. Ophthalmic Res 39(2):116–120

    Article  PubMed  CAS  Google Scholar 

  7. Munoz G, Lopez-Corell MP, Taboada JF et al (1994) Fuch’s heterochromic cyclitis and HLA histocompatibility antigens. Int Ophthalmol 18(3):127–130

    Article  PubMed  CAS  Google Scholar 

  8. de Groot-Mijnes JD, de Visser L, Rothova A et al (2006) Rubella virus is associated with Fuch’s heterochromic iridocyclitis. Am J Ophthalmol 141(1):212–214

    Article  PubMed  Google Scholar 

  9. Quentin CD, Reiber H (2004) Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 138(1):46–54

    Article  PubMed  Google Scholar 

  10. de Visser L, Braakenburg A, Rothova A, de Boer JH (2008) Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol 146(2):292–297

    Article  PubMed  Google Scholar 

  11. Teyssot N, Cassoux N, Lehoang P, Bodaghi B (2005) Fuchs heterochromic cyclitis and ocular toxocariasis. Am J Ophthalmol 139(5):915–916

    Article  PubMed  Google Scholar 

  12. Barequet IS, Li Q, Wang Y et al (2000) Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol 129(5):672–673

    Article  PubMed  CAS  Google Scholar 

  13. Chee SP, Jap A (2008) Presumed Fuch’s heterochromic iridocyclitis and Posner–Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol 146(6):883–889 e1

    Article  PubMed  Google Scholar 

  14. Ganesh SK, Sharma S, Narayana KM, Biswas J (2004) Fuchs’ heterochromic iridocyclitis following bilateral ocular toxoplasmosis. Ocul Immunol Inflamm 12(1):75–77

    Article  PubMed  Google Scholar 

  15. Parrat E, Brousse D, Cousin P et al (1999) Fuchs’ uveitic syndrome in a patient with ocular toxoplasmosis. J Fr Ophtalmol 22(10):1067–1071

    PubMed  CAS  Google Scholar 

  16. Toledo de Abreu M, Belfort R Jr, Hirata PS (1982) Fuchs’ heterochromic cyclitis and ocular toxoplasmosis. Am J Ophthalmol 93(6):739–744

    PubMed  CAS  Google Scholar 

  17. Schwab IR (1991) The epidemiologic association of Fuchs’ heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol 111(3):356–362

    PubMed  CAS  Google Scholar 

  18. Gilbert RE, Stanford MR, Jackson H et al (1995) Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ 310(6986):1037–1040

    Article  PubMed  CAS  Google Scholar 

  19. Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509–516

    Article  PubMed  Google Scholar 

  20. la Hey E, Baarsma GS, Rothova A et al (1988) High incidence of corneal epithelium antibodies in Fuch’s heterochromic cyclitis. Br J Ophthalmol 72(12):921–925

    Article  PubMed  Google Scholar 

  21. La Hey E, Broersma L, van der Gaag R et al (1993) Does autoimmunity to S-antigen play a role in Fuchs’ heterochromic cyclitis? Br J Ophthalmol 77(7):436–439

    Article  PubMed  Google Scholar 

  22. Muhaya M, Calder VL, Towler HM et al (1999) Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol 116(3):410–414

    Article  PubMed  CAS  Google Scholar 

  23. Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85(1):9–18 quiz 21

    Article  PubMed  CAS  Google Scholar 

  24. Labalette P, Caillau D, Grutzmacher C et al (2002) Highly focused clonal composition of CD8(+) CD28(neg) T cells in aqueous humor of Fuchs heterochromic cyclitis. Exp Eye Res 75(3):317–325

    PubMed  CAS  Google Scholar 

  25. Davidson, MG, Lappin MR et al (1993) A feline model of ocular toxoplasmosis. Invest Ophthalmol Vis Sci 34(13):3653–3660

    Google Scholar 

  26. La Hey E, Baarsma GS (1993) Contralateral active ocular toxoplasmosis in Fuchs’ heterochromic cyclitis. Br J Ophthalmol 77(7):455–456

    Article  PubMed  Google Scholar 

  27. La Hey E, de Jong PT, Kijlstra A (1994) Fuchs’ heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol 78(4):307–312

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akesbi Jad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jad, A., Céline, T., Bahram, B. et al. Fuchs’ heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?. Int Ophthalmol 33, 189–194 (2013). https://doi.org/10.1007/s10792-012-9649-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9649-7

Keywords

Navigation